We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Global study

News List

Global study by Novartis and European Migraine and Headache Alliance reveals 60% of employed people with severe migraine miss, on average, a week of work per month worldpharmanews
July 05, 2018
Novartis and the European Migraine and Headache Alliance (EMHA) announced initial findings from the largest global migraine patient study to date, involving over 11,000 people from 31 countries.
Global study sets new standard to personalise chemotherapy europeanpharmaceuticalreview
June 12, 2017
“In this case, less is more. We’re now able to spare many patients with colon cancer unnecessary side effects of an additional 3 months of chemotherapy without compromising results.